| 摘要 |
<p>Agents for ameliorating symptoms caused by joint diseases relating to PTH or PTHrP. It is found out that joint diseases and symptoms caused by joint diseases can be ameliorated by a substance inhibiting the binding of a parathyroid hormone-related peptide to its receptor. Namely, agents for ameliorating symptoms caused by joint diseases which contain as the active ingredient the substance inhibiting the binding of a parathyroid hormone-related peptide to its receptor.</p> |
